Arkolith/Insider Trading/CGON/Form 4

Mulay James

DirectorCG Oncology, Inc. (CGON) · full profile →Form 4 · filed Sep 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$500K
Net Open-Market Flow
-$500K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 29, 2025Option exercise(M)13K$1.82$23K13K
Sep 29, 2025Sell(S)13K$39.19$500K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 29, 2025Option exercise(M)13K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-225133) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML